Your search history is turned on.
Date: August 14, 2012 Jurisdictions: Alberta, British Columbia, Manitoba, New Brunswick, Ontario, Price Edward Island, Quebec, Saskatchewan
Microsoft Word - meru0814 MERUS LABS INTERNATIONAL INC. ANNOUNCES THIRD QUARTER RESULTS FOR FISCAL 2012 Toronto, August 14, 2012 - Merus Labs International Inc. ("Merus" or the Company") [TSX: MSL, NASDAQ: MSLI] is pleased to announce today its financial results for the third quarter of fiscal 2012. The results from the third quarter of fiscal 2...
Microsoft Word - CEO.doc 12276928.1 FORM 52-109F2 CERTIFICATION OF INTERIM FILINGS FULL CERTIFICATE I, Elie Farah, Chief Executive Officer of Merus Labs International Inc., certify the following: 1. Review: I have reviewed the interim financial statements and interim MD&A (together, the interim filings) of Merus Labs International Inc. (the issu...
Microsoft Word - CFO.doc 12276928.1 FORM 52-109F2 CERTIFICATION OF INTERIM FILINGS FULL CERTIFICATE I, Andrew Patient, Chief Financial Officer of Merus Labs International Inc., certify the following: 1. Review: I have reviewed the interim financial statements and interim MD&A (together, the interim filings) of Merus Labs International Inc. (the ...
Microsoft Word - Report Cover Merus Labs International Inc. Third Quarter Report 2012 For the Three and Nine Months Ended June 30, 2012 and 2011 As at: June 30 September 30 October 1 2012 2011 2010 Assets Current assets Cash 8,807,656$ 5,059,650$ 8,710,990$ Short-term investments n...
Microsoft Word - Report Cover MERUS LABS INTERNATIONAL INC. MANAGEMENTS DISCUSSION AND ANALYSIS For the three and nine months ended June 30, 2012 and 2011 The following discussion is managements assessment and analysis of the results and financial condition of Merus Labs International Inc. (the Company or Merus) and should be read in conjunction with the ...
Date: July 16, 2012 Jurisdictions: Alberta, British Columbia, Manitoba, New Brunswick, Ontario, Price Edward Island, Quebec, Saskatchewan
CREDIT AGREEMENT dated as of July 10, 2012 among MERUS LABS INTERNATIONAL INC., as Borrower, MERUS LABS LUXCO S. R.L, MERUS LABS INC., ECG HOLDINGS INC., and MERUS LABS NETHERLANDS B.V. as Loan Parties, PDL BIOPHARMA, INC., as Lender, and PDL BIOPHARMA, INC., as Agent i ...
Microsoft Word - Enablex APA Redacted Final.doc ___________________________________________________________________ ASSET PURCHASE AGREEMENT between NOVARTIS PHARMA AG AND MERUS LABS LUXCO SARL ___________________________________________________________________ TableofContents 1. Definiti...
Microsoft Word - MCR.DOCX CW5457658.1 51-102F3 MATERIAL CHANGE REPORT Item 1 Name and Address of Company Merus Labs International Inc. 470 Granville Street, Suite 503 Vancouver, BC V6C 1V5 Item 2 Date of Material Change July 10, 2012 Item 3 News Release The news release was issued on July 11, 2012 through Marketwire. Item 4 Summar...
Date: July 11, 2012 Jurisdictions: Alberta, British Columbia, Manitoba, New Brunswick, Ontario, Price Edward Island, Quebec, Saskatchewan
Microsoft Word - MERUS LABS INTERNATIONAL INC JULY 11 2012 PR FINAL.docx MERUS LABS INTERNATIONAL INC. ANNOUNCES ACQUISITION OF EMSELEX/ENABLEX Toronto, July 11, 2012 - Merus Labs International Inc. (Merus or the Company) [TSX: MSL, NASDAQ: MSLI] is pleased to announce that it has acquired from Novartis Pharma AG (Novartis) the Canadian an...
Date: July 9, 2012 Jurisdictions: Alberta, British Columbia, Manitoba, New Brunswick, Ontario, Price Edward Island, Quebec, Saskatchewan